Arrowstreet Capital’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.76M | Sell |
49,917
-677,098
| -93% | -$65M | ﹤0.01% | 1301 |
|
|
2026
Q1 | $75.3M | Sell |
727,015
-892,381
| -55% | -$101M | 0.04% | 378 |
|
|
2025
Q4 | $163M | Buy |
1,619,396
+142,463
| +10% | +$15.5M | 0.1% | 212 |
|
|
2025
Q3 | $182M | Buy |
1,476,933
+227,806
| +18% | +$28.3M | 0.11% | 176 |
|
|
2025
Q2 | $150M | Buy |
1,249,127
+856,873
| +218% | +$114M | 0.11% | 183 |
|
|
2025
Q1 | $57.8M | Buy |
392,254
+265,838
| +210% | +$40.6M | 0.05% | 343 |
|
|
2024
Q4 | $20.5M | Sell |
126,416
-37,115
| -23% | -$6.07M | 0.02% | 598 |
|
|
2024
Q3 | $26.6M | Buy |
163,531
+143,393
| +712% | +$21.2M | 0.02% | 472 |
|
|
2024
Q2 | $2.75M | Buy |
+20,138
| New | +$2.8M | ﹤0.01% | 996 |
|
|
2023
Q4 | – | Sell |
-495,596
| Closed | -$65M | – | 1418 |
|
|
2023
Q3 | $65M | Buy |
495,596
+136,755
| +38% | +$20.8M | 0.08% | 207 |
|
|
2023
Q2 | $57.1M | Buy |
358,841
+353,172
| +6,230% | +$57M | 0.07% | 226 |
|
|
2023
Q1 | $897K | Buy |
5,669
+827
| +17% | +$124K | ﹤0.01% | 1085 |
|
|
2022
Q4 | $679K | Buy |
+4,842
| New | +$687K | ﹤0.01% | 1091 |
|
|
2022
Q3 | – | Sell |
-1,963
| Closed | -$277K | – | 1290 |
|
|
2022
Q2 | $277K | Buy |
+1,963
| New | +$280K | ﹤0.01% | 1128 |
|
|
2022
Q1 | – | Sell |
-5,877
| Closed | -$1.02M | – | 1236 |
|
|
2021
Q4 | $1.02M | Buy |
+5,877
| New | +$980K | ﹤0.01% | 1161 |
|
|
2021
Q2 | – | Sell |
-26,700
| Closed | -$5.15M | – | 1928 |
|
|
2021
Q1 | $5.15M | Sell |
26,700
-827,062
| -97% | -$159M | 0.01% | 1162 |
|
|
2020
Q4 | $172M | Sell |
853,762
-8,207
| -1% | -$1.7M | 0.24% | 73 |
|
|
2020
Q3 | $181M | Buy |
861,969
+736,152
| +585% | +$164M | 0.29% | 60 |
|
|
2020
Q2 | $27.6M | Buy |
125,817
+113,717
| +940% | +$22.7M | 0.05% | 375 |
|
|
2020
Q1 | $2.1M | Buy |
+12,100
| New | +$2M | 0.01% | 1049 |
|
|
2019
Q4 | – | Sell |
-19,500
| Closed | -$2.96M | – | 1765 |
|
|
2019
Q3 | $2.96M | Buy |
+19,500
| New | +$3.08M | 0.01% | 860 |
|
|
2018
Q1 | – | Sell |
-6,300
| Closed | -$937K | – | 1147 |
|
|
2017
Q4 | $937K | Buy |
+6,300
| New | +$857K | ﹤0.01% | 974 |
|
|
2017
Q3 | – | Sell |
-220,848
| Closed | -$29.4M | – | 1120 |
|
|
2017
Q2 | $29.4M | Buy |
220,848
+16,412
| +8% | +$2.21M | 0.09% | 204 |
|
|
2017
Q1 | $27.6M | Buy |
+204,436
| New | +$26.5M | 0.1% | 207 |
|
|
2016
Q4 | – | Sell |
-701,496
| Closed | -$87.8M | – | 1773 |
|
|
2016
Q3 | $87.8M | Buy |
701,496
+438,316
| +167% | +$57.4M | 0.29% | 79 |
|
|
2016
Q2 | $36.4M | Buy |
263,180
+22,880
| +10% | +$2.97M | 0.12% | 174 |
|
|
2016
Q1 | $30.3M | Buy |
240,300
+174,800
| +267% | +$22.2M | 0.13% | 174 |
|
|
2015
Q4 | $8.31M | Sell |
65,500
-59,912
| -48% | -$7.44M | 0.04% | 404 |
|
|
2015
Q3 | $14.5M | Buy |
125,412
+105,012
| +515% | +$11.8M | 0.07% | 258 |
|
|
2015
Q2 | $2.12M | Buy |
20,400
+15,900
| +353% | +$1.72M | 0.01% | 619 |
|
|
2015
Q1 | $497K | Buy |
+4,500
| New | +$489K | ﹤0.01% | 838 |
|
|
2014
Q4 | – | Sell |
-12,717
| Closed | -$1.22M | – | 1240 |
|
|
2014
Q3 | $1.22M | Buy |
+12,717
| New | +$1.15M | 0.01% | 690 |
|
|
2014
Q2 | – | Sell |
-71,098
| Closed | -$6.26M | – | 1007 |
|
|
2014
Q1 | $6.26M | Buy |
+71,098
| New | +$6.24M | 0.04% | 398 |
|
|
2013
Q4 | – | Sell |
-63,221
| Closed | -$5.17M | – | 1164 |
|
|
2013
Q3 | $5.17M | Sell |
63,221
-98,705
| -61% | -$8.33M | 0.03% | 378 |
|
|
2013
Q2 | $13.5M | Buy |
+161,926
| New | +$13.9M | 0.1% | 185 |
|
Other funds holding CLX
Arrowstreet Capital's CLX Position: Q2 2026 in Review
Arrowstreet Capital reduced its Clorox (CLX) stake by 93% in Q2 2026, selling an estimated $65M and leaving 49,917 shares worth $4.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1301.
Arrowstreet Capital first reported a position in CLX in Q2 2013 and has held it in 35 quarters since. The position peaked at $182M in Q3 2025. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Arrowstreet Capital held 49,917 shares of Clorox worth $4.76M as of Q2 2026.
- Arrowstreet Capital sold 677,098 Clorox shares in Q2 2026, an estimated $65M.
- Clorox made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1301 holding.
- Arrowstreet Capital first reported a position in Clorox in Q2 2013 and has held it in 35 quarters since.
- Arrowstreet Capital's Clorox position peaked at $182M in Q3 2025.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.